Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.

Vet Dermatol · 2013 · PMC4282347 · PMID 23829933

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantP ≤ 0.0001actually significant

There was a highly significant improvement ( P ≤ 0.0001) for all of the efficacy variables in oclacitinib-treated dogs compared with placebo-treated dogs.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.